Tag: 333

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million.

迈阿密, June 17, 2026 (GLOBE NEWSWIRE) -- 主题型及杠杆型交易所交易基金领域的领军者 Defiance ETFs 今日宣布，Cboe BZX Exchange, Inc.（简称“交易所”）已授权恢复 Defiance Daily 2X Space ETF (Cboe BZX 交易所代码：SPCL) 份额的交易。此前，该基金于 2026 年 6 月 12 日被交易所临时停牌。

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- PAVS (NASDAQ:PAVS) (the "Company"), a consumer products and digital commerce solutions company, today announced that it has entered into a definitive agreement with certain institutional investors for a registered direct offering of an aggregate of 50,000,000 Class A ordinary shares (or pre-funded warrants to purchase Class A ordinary shares in lieu thereof) at a purchase price of $0.20 per share. The gross proceeds to the Company from the offering are expected to be approximately $10 million, before deducting offering expenses.

COMPANY ANNOUNCEMENT NO. 30-2026
FLSmidth & Co. A/S
15 June 2026
Copenhagen, Denmark

迈阿密, June 14, 2026 (GLOBE NEWSWIRE) -- 主题型及杠杆型交易所交易基金领域的领军者 Defiance ETFs 今日宣布，Defiance Daily 2X Space ETF (Cboe BZX 交易所代码：SPCL) 份额的交易已被 Cboe BZX Exchange, Inc.（简称“交易所”）临时暂停。